Table 4.

Guidelines for CMV management in SCT: CMV disease treatment. ECIL recommendations⁶⁸

CMV pneumonia (allo-SCT) ○ Ganciclovir is recommended (AII) ○ Foscarnet might be used in place of ganciclovir (AIII) ○ The addition of immune globulin to antiviral therapy should be considered (CII) ○ Cidofovir or the combination of foscarnet and ganciclovir can be used as second-line therapy (BII). Other types of CMV disease and in other patients groups ○ Ganciclovir or foscarnet without Ig is recommended (BII) ○ Cidofovir or the combination of i.v. ganciclovir and foscarnet can be used as second-line therapy for CMV disease (BII).